Mirum Pharmaceuticals

Developer of small molecule based therapeutics to treat rare diseases

placeMenlo Park, California, United States calendar_todayFounded 2018 groups196 employees language mirumpharma.com

Registered entities

Innovation

10 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 1,449 times.

YearFilings
20201
20211
20221
20234
20247
202510
20264

Social engagement

Social engagement: 46.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include New Enterprise Associates; 1 has since exited.

Investor typeCountShare
Venture capital655%
Private equity327%
Bank & private debt19%
Other / undisclosed19%

Hiring activity

Hires periodically

15 roles tracked across 4 of the last 12 months

10 Jun 2026 · Senior Director, US Market Access · San Mateo

10 Jun 2026 · Associate Director, Patient Services Operations · Charlotte

10 Jun 2026 · Associate Director, Regulatory Affairs Advertising and Promotion · San Mateo

10 Jun 2026 · Director, Medical Writing · San Mateo

10 Jun 2026 · Associate Director, GCP QA · San Mateo

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Event
PrideMonth Networking Event
23 Jun 2026
Event
European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2026
Coming soon